Prescott Group staff members' contributions to the medical literature include the following publications:
Simplification to single-tablet regimen of elvitegravir, cobicistat, emtricitabine, tenofovir DF from multi-tablet ritonavir-boosted protease inhibitor plus coformulated emtricitabine and tenofovir DF regimens: Week 96 results of STRATEGY-PI.
Arribas JR, DeJesus E, van Lunzen J, et al. HIV Clin Trials. 2017;18(3):118-125.